Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Hantaan virus glycoprotein Gn is an envelope glycoprotein encoded by the M segment of the viral genome as part of a precursor polyprotein (GPC) that is cleaved to yield mature Gn and Gc. Gn forms heterodimers with Gc, which assemble into tetrameric spikes on the viral surface, creating a characteristic square lattice essential for virion structure and host cell interaction. It mediates attachment to host cell receptors, such as integrins like ITGAV/ITGB3, facilitating receptor-mediated endocytosis during virus entry, while shielding the fusion loop on Gc until low pH triggers fusion in endosomes. Gn also plays critical roles in virus assembly and budding at the Golgi apparatus or plasma membrane, interacting via its cytoplasmic tail with viral nucleocapsids to link envelope and internal components, acting as a matrix surrogate. As a key component of pathogenic hantaviruses like Hantaan virus, which causes hemorrhagic fever with renal syndrome, Gn is the primary target of neutralizing antibodies, driving efforts in immunogen design, though no approved antiviral drugs target it directly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hantaan virus glycoprotein Gn (Gn).